Jeff Yass’s Sanofi Contingent Value Rights GCVRZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-271,641
| Closed | -$234K | – | 11453 |
|
|
2019
Q4 | $234K | Sell |
271,641
-130,803
| -33% | -$100K | ﹤0.01% | 8488 |
|
|
2019
Q3 | $226K | Sell |
402,444
-102,295
| -20% | -$55K | ﹤0.01% | 8870 |
|
|
2019
Q2 | $262K | Buy |
504,739
+104,233
| +26% | +$52.1K | ﹤0.01% | 8586 |
|
|
2019
Q1 | $180K | Buy |
400,506
+144,034
| +56% | +$67.2K | ﹤0.01% | 7940 |
|
|
2018
Q4 | $123K | Buy |
256,472
+131,437
| +105% | +$65.3K | ﹤0.01% | 8112 |
|
|
2018
Q3 | $66K | Sell |
125,035
-263,308
| -68% | -$141K | ﹤0.01% | 8762 |
|
|
2018
Q2 | $194K | Buy |
388,343
+29,022
| +8% | +$13.5K | ﹤0.01% | 8639 |
|
|
2018
Q1 | $152K | Sell |
359,321
-6,124
| -2% | -$2.46K | ﹤0.01% | 8521 |
|
|
2017
Q4 | $139K | Buy |
365,445
+129,249
| +55% | +$49K | ﹤0.01% | 8535 |
|
|
2017
Q3 | $85K | Sell |
236,196
-2,811
| -1% | -$1.04K | ﹤0.01% | 8418 |
|
|
2017
Q2 | $91K | Buy |
239,007
+111,518
| +87% | +$45.5K | ﹤0.01% | 8724 |
|
|
2017
Q1 | $57K | Sell |
127,489
-78,104
| -38% | -$34.3K | ﹤0.01% | 8568 |
|
|
2016
Q4 | $78K | Buy |
205,593
+180,272
| +712% | +$61K | ﹤0.01% | 9177 |
|
|
2016
Q3 | $7K | Buy |
+25,321
| New | +$6.41K | ﹤0.01% | 8299 |
|
|
2016
Q2 | – | Sell |
-128,117
| Closed | -$15K | – | 10165 |
|
|
2016
Q1 | $15K | Buy |
128,117
+66,259
| +107% | +$7.18K | ﹤0.01% | 8851 |
|
|
2015
Q4 | $7K | Buy |
+61,858
| New | +$8.73K | ﹤0.01% | 9316 |
|
|
2014
Q1 | – | Sell |
-143,235
| Closed | -$49K | – | 10110 |
|
|
2013
Q4 | $49K | Sell |
143,235
-74,400
| -34% | -$89.9K | ﹤0.01% | 8807 |
|
|
2013
Q3 | $440K | Sell |
217,635
-5,151
| -2% | -$9.81K | ﹤0.01% | 6621 |
|
|
2013
Q2 | $423K | Buy |
+222,786
| New | +$391K | ﹤0.01% | 6294 |
|
Jeff Yass's GCVRZ Position: Q1 2020 in Review
Jeff Yass sold out of Sanofi Contingent Value Rights (GCVRZ) in Q1 2020, closing a stake of 271,641 shares — an estimated $234K sold.
Jeff Yass first reported a position in GCVRZ in Q2 2013 and held it in 19 quarters. The position peaked at $440K in Q3 2013. 2 funds tracked by Wall St. Rank hold GCVRZ as of Q1 2020.
- Jeff Yass reported no remaining Sanofi Contingent Value Rights position as of Q1 2020 after selling out during the quarter.
- Jeff Yass sold 271,641 Sanofi Contingent Value Rights shares in Q1 2020, an estimated $234K.
- Jeff Yass first reported a position in Sanofi Contingent Value Rights in Q2 2013 and held it in 19 quarters.
- Jeff Yass's Sanofi Contingent Value Rights position peaked at $440K in Q3 2013.
- 2 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q1 2020.
Based on Susquehanna International Group's 13F filing for Q1 2020, filed 15 May 2020.